Publications by authors named "N Anderegg"

Claim this Profile
T
The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study.
Nuri Han, Tom Loosli, Nanina Anderegg, Anthony Hauser, Johannes Josi

Lancet Glob Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel integrase mutations linked to genotypic DTG resistance in non-B HIV-1 strains from African participants: The DTG RESIST study.
N Han, T Loosli, M Sauermann, I Çelikağ, N Anderegg

medRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.
Gabriela Patten, Karen Malateste, Carolyn Bolton Moore, Nosisa Sipambo, Limpho Mokone, Nanina Anderegg

Pediatr Infect Dis J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange.
Patience Nyakato, Michael Schomaker, Andrew Boulle, Jonathan Euvrard, Robin Wood, Nanina Anderegg

Trop Med Int Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study.
Tinei Shamu, Matthias Egger, Tinashe Mudzviti, Cleophas Chimbetete, Justen Manasa, Nanina Anderegg

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis